Buscar
24/04/2026
Blood biomarkers in neurodegenerative diseases: pre-analytical, analytical, and post-analytical challenges
Delaby, C, Lehmann, S. Blood biomarkers in neurodegenerative diseases: pre-analytical, analytical, and post-analytical challenges. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2026; 64(5)DOI:10.1515/cclm-2025-1731. PMID:41630537. IF:3.700(Q1/1D).
24/04/2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)
Llamas-Velasco, M, Hospital, M, López-Ferrer, A, Herranz, P, Ruíz-Villaverde, R, Mateu, A, García-Latasa, FJ, Rivera, R, Fernández-Freire, LR, Alcazar, ED, Santos, S, Arias, S, Gónzalez-Cantero, A, Belinchon, I, Carretero, G, Ferran, M, Ruiz-Genao, D, Eiris, N, Sahuquillo, A, Mataix, J, Carrascosa, JM, Cueva, PD, Salgado-Boquete, L. Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS). Pharmacy. 2026; 14(3)DOI:10.3390/pharmacy14030063. PMID:42200950. IF:(Q/D).
23/04/2026
Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis
Cerro-Pardo, I, Picatoste, B, Raposo-Gutiérrez, I, Martos-Folgado, I, Márquez-Gálvez, C, García-García, A, Ortega-Villanueva, L, Mur, SM, Robles-Vera, I, Escolà-Gil, JC, Núñez, E, Sancho, D, Lindholt, J, Vázquez, J, Blanco-Colio, LM, Ramiro, AR, Martín-Ventura, JL. Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis. Frontiers in Immunology. 2026; 17DOI:10.3389/fimmu.2026.1774396. PMID:42112342. IF:5.900(Q1/2D).
22/04/2026
Luteinizing hormone activity in ovarian stimulation: comparative efficacy and safety of gonadotropins versus recombinant follicle-stimulating hormone-a systematic review and meta-analysis
Espinós, JJ, Checa, MA, Villegas-Arbelaez, E, Martínez-Zapata, MJ. Luteinizing hormone activity in ovarian stimulation: comparative efficacy and safety of gonadotropins versus recombinant follicle-stimulating hormone-a systematic review and meta-analysis. Frontiers in Endocrinology. 2026; 17DOI:10.3389/fendo.2026.1792900. PMID:42100203. IF:4.600(Q1/3D).
21/04/2026
Biomarkers for Cardiovascular Drug Development
Aimo, A, Butler, J, De Michieli, L, Mendieta, G, Zannad, F, Januzzi, JL. Biomarkers for Cardiovascular Drug Development. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2026; 87(15)DOI:10.1016/j.jacc.2025.12.072. PMID:41670555. IF:22.300(Q1/1D).
21/04/2026
LRP5, a WNT signalling pathway receptor, and platelet activation
Luquero, A, Pimentel, N, Vilahur, G, Borrell-Pages, M, Badimon, L. LRP5, a WNT signalling pathway receptor, and platelet activation. EUROPEAN HEART JOURNAL. 2026; 47(16)DOI:10.1093/eurheartj/ehaf772. PMID:41042971. IF:35.600(Q1/1D).
21/04/2026
Emotional wellbeing in schoolchildren and teachers during the COVID-19 pandemic: an intervention study
Toledo, MD, da Costa, PRG, Borras-Santos, A, Llupià, A, Amo, I, Ginesta, MM. Emotional wellbeing in schoolchildren and teachers during the COVID-19 pandemic: an intervention study. Frontiers In Education. 2026; 11DOI:10.3389/feduc.2026.1732462. PMID:. IF:(Q/D).
21/04/2026
Clarifying the SOFA-2 Score-Reply
Ranzani, OT, Singer, M, Moreno, RP. Clarifying the SOFA-2 Score-Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2026; 335(15)DOI:10.1001/jama.2026.0313. PMID:41837958. IF:55.000(Q1/1D).